Quirante, Ginalyn .

HRN: 24-42-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2025
CEFUROXIME 1.5GM (VIAL)
05/24/2025
05/25/2025
IV
1.5g
Q8h X 3 Doses
S/p D&C
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: